Silymarin Accelerates Liver Regeneration after Partial Hepatectomy

Area of Science:

• Hepatology
• Molecular Biology
• Pharmacology

Background:

• Partial hepatectomy (PHx) triggers physiological liver regeneration to maintain homeostasis.
• Silymarin (Sm) is known for antioxidant and anticarcinogen properties, with its role in liver regeneration being explored.
• The supportive role of silymarin in treating liver damage requires further elucidation.

Purpose of the Study:

• To investigate the effect of silymarin on hepatic regeneration following partial hepatectomy.
• To determine if silymarin can accelerate the cell cycle and enhance growth factor expression in regenerating liver tissue.

Main Methods:

• Male Sprague-Dawley rats were administered silymarin (25 mg/kg) for 7 weeks.
• Surgical 2/3 partial hepatectomy was performed, followed by sample collection at 6, 24, and 72 hours.
• Western blot and RT-PCR analyses were used to assess cell cycle activity and gene expression.

Main Results:

• Silymarin administration enhanced liver regeneration by accelerating cell cycle progression in PHx liver.
• Increased protein and mRNA levels of G1, S, G2, and M phase markers (cyclin D1/pRb, cyclin E/E2F, cyclin B, cyclin A) were observed.
• Expressions of hepatocyte growth factor (HGF), TGFα, and TGFβ1 were significantly enhanced.

Conclusions:

• Silymarin plays a crucial role in accelerating liver regeneration after partial hepatectomy.
• The compound promotes liver recovery by modulating cell cycle regulators and growth factors.
• Silymarin shows potential as a supportive treatment for liver damage and post-surgical recovery.